Published • loading... • Updated
Pfizer COVID-19 vaccine sales tumble after government guidance on the shots narrows
Pfizer raised profit guidance despite a 25% drop in U.S. COVID-19 vaccine sales due to narrowed federal recommendations and delayed updated shot approvals.
- U.S. COVID-19 vaccine sales for Pfizer have declined by 25% after the Centers for Disease Control and Prevention stopped recommending the shots for everyone.
- The CDC now leaves the choice of getting a COVID-19 vaccine up to patients, following recommendations from advisers picked by Health Secretary Robert F. Kennedy Jr.
- The shifting guidance has caused confusion, with some locations requiring prescriptions or asking about susceptibility to severe COVID-19, raising questions about insurance coverage.
Insights by Ground AI
46 Articles
46 Articles
Pfizer COVID-19 vaccine sales tumble after government guidance on the shots narrows (Business)
The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them. Approval of updated shots also came several weeks later than usual, and Pfizer said Tuesday that hurt sales as ...
·Kelowna, Canada
Read Full ArticleReposted by
Independent Español
Sales in the United States of Pfizer's Commonwealth vaccines fell 25% after federal regulators reduced recommendations on who should receive them, just as the COVID-19 vaccination season begins.
·Calhoun, United States
Read Full ArticlePfizer Raises 2025 Profit Forecast for Second Time in a Row
·New York, United States
Read Full Article+22 Reposted by 22 other sources
Pfizer COVID-19 vaccine sales tumble after government guidance on the shots narrows
The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them.
·United States
Read Full ArticleCoverage Details
Total News Sources46
Leaning Left10Leaning Right5Center16Last UpdatedBias Distribution52% Center
Bias Distribution
- 52% of the sources are Center
52% Center
L 32%
C 52%
R 16%
Factuality
To view factuality data please Upgrade to Premium




















